[Pharmacological properties of a new gastric secretion inhibitor: (pyridyl-2)-2-thioacetamide (CMN 131)].
D000081:Acetamides / Q000494:pharmacology; D000085:Acetates / Q000494:pharmacology*; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D005750:Gastric Juice / Q000187:drug effects; D008297:Male; D010437:Peptic Ulcer / Q000517:prevention & control*; D051381:Rats; D013270:Stomach / Q000187:drug effects*
D000081:Acetamides; D000085:Acetates; D000577:Amides; D001285:Atropine
Propriétés pharmacologiques d'un nouvel inhibiteur de la étion gastrique: le (pyridyl-2)-2-thioacétamide (CMN 131.